CEO: Jayson Donald Alexander Dallas

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Aimmune Therapeutics Inc is engaged in the field of biotechnology. It researches and develops drug candidates for the treatment of peanut and other food allergies.


Key numbers

Market Capitalization:1688202999
Shares Outstanding: 63299700
Float: 39681569.1348
Next Earning Date:2020-02-27
TTm EPS: -3.8666
TTm Dividend Rate:
200 days moving average:22.05
50 days moving average: 24.94
One day percent Change: 2.76



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,